We recently demonstrated that iASPP is mainly distributed in the cytoplasm under unstressed conditions in the majority of cancer types, where it elicits oncogenic activity by stabilizing anti-oxidative Nrf2 in a p53-independent manner [39]. This evidence concerns the gene TP53 and cancer.